awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33629947-204A9012-23E9-41CB-BC1B-352AFFE9298C
Q33629947-204A9012-23E9-41CB-BC1B-352AFFE9298C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33629947-204A9012-23E9-41CB-BC1B-352AFFE9298C
A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer.
P2860
Q33629947-204A9012-23E9-41CB-BC1B-352AFFE9298C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33629947-204A9012-23E9-41CB-BC1B-352AFFE9298C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
552af1aa18bc0bfb6caa03b73f4bdc5756233213
P2860
Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31.